B. Kallinowski

2.3k total citations
54 papers, 1.6k citations indexed

About

B. Kallinowski is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, B. Kallinowski has authored 54 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hepatology, 33 papers in Epidemiology and 7 papers in Rheumatology. Recurrent topics in B. Kallinowski's work include Hepatitis C virus research (34 papers), Hepatitis B Virus Studies (27 papers) and Liver Disease Diagnosis and Treatment (18 papers). B. Kallinowski is often cited by papers focused on Hepatitis C virus research (34 papers), Hepatitis B Virus Studies (27 papers) and Liver Disease Diagnosis and Treatment (18 papers). B. Kallinowski collaborates with scholars based in Germany, United States and Spain. B. Kallinowski's co-authors include Tobias Goeser, Lorenz Theilmann, Wolfgang Stremmel, Christine Solbach, Eberhard Pfaff, Peter Buggisch, Thomas Berg, Stefan Zeuzem, Hanna M. Müller and U. Alshüth and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Hepatology.

In The Last Decade

B. Kallinowski

54 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Kallinowski Germany 20 1.3k 1.1k 153 135 129 54 1.6k
Vijayan Balan United States 27 1.5k 1.2× 1.1k 1.0× 117 0.8× 136 1.0× 207 1.6× 63 2.3k
Greg Galler United States 9 1.2k 0.9× 1.7k 1.6× 193 1.3× 81 0.6× 210 1.6× 13 2.4k
Mauricio Lisker‐Melman United States 23 2.3k 1.8× 2.0k 1.8× 378 2.5× 125 0.9× 248 1.9× 79 2.8k
Mauro Viganò Italy 27 2.2k 1.7× 2.4k 2.1× 88 0.6× 115 0.9× 285 2.2× 131 2.9k
P. Puri India 27 651 0.5× 563 0.5× 134 0.9× 70 0.5× 140 1.1× 154 2.3k
Sabahattin Kaymakoğlu Türkiye 23 1.0k 0.8× 1.1k 1.0× 79 0.5× 85 0.6× 250 1.9× 147 1.9k
Antonio González Spain 20 2.5k 2.0× 2.3k 2.0× 84 0.5× 88 0.7× 157 1.2× 31 3.0k
Stephen T. Barclay United Kingdom 20 828 0.7× 792 0.7× 68 0.4× 49 0.4× 85 0.7× 79 1.2k
Paulo Lisboa Bittencourt Brazil 21 2.1k 1.7× 1.9k 1.7× 486 3.2× 98 0.7× 33 0.3× 93 2.6k
Russell H. Wiesner United States 28 2.3k 1.9× 2.2k 1.9× 130 0.8× 658 4.9× 231 1.8× 60 4.0k

Countries citing papers authored by B. Kallinowski

Since Specialization
Citations

This map shows the geographic impact of B. Kallinowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Kallinowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Kallinowski more than expected).

Fields of papers citing papers by B. Kallinowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Kallinowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Kallinowski. The network helps show where B. Kallinowski may publish in the future.

Co-authorship network of co-authors of B. Kallinowski

This figure shows the co-authorship network connecting the top 25 collaborators of B. Kallinowski. A scholar is included among the top collaborators of B. Kallinowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Kallinowski. B. Kallinowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berg, Thomas, Michael Wagner, Samer Nasser, et al.. (2006). Extended Treatment Duration for Hepatitis C Virus Type 1: Comparing 48 Versus 72 Weeks of Peginterferon-Alfa-2a Plus Ribavirin. Gastroenterology. 130(4). 1086–1097. 368 indexed citations
2.
Merle, Uta, Franziska Theilig, Evelyn Fein, et al.. (2006). Localization of the iron-regulatory proteins hemojuvelin and transferrin receptor 2 to the basolateral membrane domain of hepatocytes. Histochemistry and Cell Biology. 127(2). 221–226. 18 indexed citations
3.
Sanjosé, Sílvia de, Alexandra Nieters, James J. Goedert, et al.. (2004). Role of hepatitis C virus infection in malignant lymphoma in Spain. International Journal of Cancer. 111(1). 81–85. 33 indexed citations
4.
Schwake, Lukas, U Müller, Lorenz Theilmann, et al.. (2003). Klinischer Nutzen und diagnostische Bedeutung der Leberbiopsie bei chronisch erhöhten Leberwerten nicht viraler Genese. Zeitschrift für Gastroenterologie. 41(4). 303–309. 6 indexed citations
5.
Kallinowski, B., Olaf Hergesell, & Martin Zeier. (2002). Clinical Impact of Hepatitis C Virus Infection in the Renal Transplant Recipient. ˜The œNephron journals/Nephron journals. 91(4). 541–546. 3 indexed citations
6.
Kallinowski, B., et al.. (2002). Clinical impact of hepatitis G virus infection in heart and liver transplant recipients. Transplantation Proceedings. 34(6). 2288–2291. 5 indexed citations
7.
Sauer, Peter, et al.. (2002). Prophylaxis of hepatitis B recurrence after liver transplantation with lamivudin and hepatitis B immunoglobulin. Transplantation Proceedings. 34(6). 2285–2287. 4 indexed citations
8.
Sauer, Peter, et al.. (2001). Immunogenicity of two accelerated hepatitis B vaccination protocols in liver transplant candidates. European Journal of Gastroenterology & Hepatology. 13(4). 363–367. 35 indexed citations
9.
Stremmel, Wolfgang, et al.. (2000). Pulmonale Sarkoidose: eine seltene Nebenwirkung einer Interferon-α-Therapie bei chronischer Hepatitis-C-Infektion. Zeitschrift für Gastroenterologie. 38(12). 951–955. 18 indexed citations
10.
Kallinowski, B., Antje Knöll, Roland Sänger, et al.. (2000). Can monovalent hepatitis A and B vaccines be replaced by a combined hepatitis A/B vaccine during the primary immunization course?. Vaccine. 19(1). 16–22. 26 indexed citations
11.
Kallinowski, B., Sabine Scherer, Arianeb Mehrabi, Lorenz Theilmann, & Wolfgang Stremmel. (1999). Clinical impact of HLA DR B1 genotypes in chronic hepatitis C virus infection. Transplantation Proceedings. 31(8). 3346–3349. 8 indexed citations
12.
Seipp, Stefanie, Tobias Goeser, Lorenz Theilmann, & B. Kallinowski. (1998). Establishment of a highly specific detection system for GB virus C (GBV-C) minus-strand RNA. Virus Research. 56(2). 183–189. 6 indexed citations
13.
Kallinowski, B., Constanze Buhrmann, Stefanie Seipp, et al.. (1998). Incidence, prevalence, and clinical outcome of hepatitis GB-C virus infection in liver transplant patients. Liver Transplantation and Surgery. 4(1). 28–33. 2 indexed citations
14.
Kallinowski, B., Rezvan Ahmadi, Stefanie Seipp, J. Bommer, & Wolfgang Stremmel. (1998). Clinical impact of GB-C virus in haemodialysis patients. Nephrology Dialysis Transplantation. 13(1). 93–98. 14 indexed citations
15.
Möhler, Markus, et al.. (1997). Case Report: Primary Hepatic High-Grade Non-Hodgkin's Lymphoma and Chronic Hepatitis C Infection. Digestive Diseases and Sciences. 42(11). 2241–2245. 24 indexed citations
16.
Kallinowski, B., H.L. Bock, Ralf Clemens, & Lorenz Theilmann. (1996). Immunogenicity and reactogenicity of a combined hepatitis A/B candidate vaccine: first results. Liver International. 16(4). 271–273. 14 indexed citations
17.
Kallinowski, B., et al.. (1994). B-lymphocytes are predominantely involved in viral propagation of hepatitis C virus (HCV). PubMed. 9. 307–316. 25 indexed citations
18.
Müller, Hanna M., Eberhard Pfaff, Tobias Goeser, et al.. (1993). Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication. Journal of General Virology. 74(4). 669–676. 205 indexed citations
19.
Gmelin, K., B. Kallinowski, Tobias Goeser, et al.. (1992). Follow-up of patients with hepatitis non-A, non-B: incidence and persistence of anti-HCV depend on route of transmission. PubMed. 4. 222–226. 1 indexed citations
20.
Kallinowski, B., K. Gmelin, B Kommerell, et al.. (1992). Immunogenicity, reactogenicity and consistency of a new, inactivated hepatitis A vaccine — a randomized multicentre study with three consecutive vaccine lots. Vaccine. 10(8). 500–501. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vijayan Balan Breakdown of academic impact, for papers by Greg Galler Breakdown of academic impact, for papers by Mauricio Lisker‐Melman Breakdown of academic impact, for papers by Mauro Viganò Breakdown of academic impact, for papers by P. Puri Breakdown of academic impact, for papers by Sabahattin Kaymakoğlu Breakdown of academic impact, for papers by Antonio González Breakdown of academic impact, for papers by Stephen T. Barclay Breakdown of academic impact, for papers by Paulo Lisboa Bittencourt Breakdown of academic impact, for papers by Russell H. Wiesner
Rankless by CCL
2026